LeukopeniaLeukocyte CountCell CountCD4 Lymphocyte CountBlood Cell CountPlatelet CountHIV InfectionsThrombocytopeniaErythrocyte CountDrug Administration ScheduleDrug EvaluationAntineoplastic Combined Chemotherapy ProtocolsViral LoadTreatment OutcomeLymphocyte CountAnti-HIV AgentsCisplatinAntiretroviral Therapy, Highly ActiveTime FactorsHIV-1NeutropeniaHematologic DiseasesFluorouracilLeukocytesColony Count, MicrobialInfusions, IntravenousProspective StudiesPaclitaxelCyclophosphamideBone MarrowSurvival AnalysisDoxorubicinAIDS-Related Opportunistic InfectionsGranulocyte Colony-Stimulating FactorDose-Response Relationship, DrugAntineoplastic Agents, PhytogenicDrug Therapy, CombinationAntineoplastic AgentsRetrospective StudiesAnemiaAnti-Retroviral AgentsCohort StudiesMastitis, BovineLung NeoplasmsCombined Modality TherapyEtoposideHematocritDisease ProgressionBone Marrow DiseasesSurvival RateAcquired Immunodeficiency SyndromeCellophaneFollow-Up StudiesCarboplatinVinblastineNauseaGastric FistulaCD4-Positive T-LymphocytesFeverLeukocytosisMilkSperm CountPrognosisRisk FactorsDeoxycytidineTaxoidsNeutrophilsGranulocytesRemission InductionHIV SeropositivityRNA, ViralDisease-Free SurvivalPhlebovirusEhrlichiaMenogarilAntimetabolites, AntineoplasticPancytopeniaNeoplasmsCD4-CD8 RatioAzathioprineSputumAgranulocytosisLymphocytesCamptothecinLevamisoleEhrlichiosisAminopterinImmunosuppressive AgentsMycophenolic AcidRecurrenceRecombinant ProteinsHematologic TestsVomitingBiological MarkersMethotrexateLeucovorinHIVAlopecia6-MercaptopurineNogalamycin